The deleterious effect of acetaminophen in cancer immunotherapy

Ann Oncol. 2022 Sep;33(9):855-856. doi: 10.1016/j.annonc.2022.06.012. Epub 2022 Jun 25.

Authors

P Berraondo¹, R J Sullivan²

Affiliations

¹ Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Department of Immunotherapy, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.
² Department of Medicine, Massachusetts General, Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA. Electronic address: RSULLIVAN7@mgh.harvard.edu.

PMID: 35764272
DOI: 10.1016/j.annonc.2022.06.012

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acetaminophen / adverse effects
Analgesics, Non-Narcotic*
Humans
Immunotherapy / adverse effects
Neoplasms* / drug therapy

Substances

Analgesics, Non-Narcotic
Acetaminophen